Correction to: Sunitinib-suppressed miR-452-5p facilitates renal cancer cell invasion and metastasis through modulating SMAD4/SMAD7 signals

Mol Cancer. 2022 Apr 6;21(1):96. doi: 10.1186/s12943-022-01568-y.
No abstract available

Publication types

  • Published Erratum